Paul Joudrey, MD, MPH
Biography
Research & Publications
Patient Care
News
Appointments
Biography
Paul Joudrey, MD MPH is an Assistant Professor in the Yale School of Medicine and a Yale Drug use, Addiction, and HIV Research (DAHRS) Scholar. Dr. Joudrey is committed to improving the health of people with substance use disorders by expanding access to high quality evidence-based care. This includes research aiming for greater equity in access to medications for opioid use disorder, particularly methadone in rural communities, as well as improving the adoption of medications for alcohol use disorder within hospital settings. He utilizes geospatial and implementation science methods to inform novel strategies for expanding access to these underutilized addiction treatments. Certified as a general internist and addiction medicine specialist, he serves as an attending physician within the Yale New Haven Hospital Primary Care Clinic, as well as attending physician for the Ledge Light Health District and Alliance for Living Coordinated, Access, Resources, Engagement, and Support (CARES) program which provides low barrier buprenorphine in New London county. He received his undergraduate degree from Case Western Reserve University and his medical degree from New York University. Dr. Joudrey completed residency training at Montefiore Medical Center in the Primary Care Social Internal Medicine program and completed the National Clinician Scholars Program fellowship at Yale School of Medicine.
Education & Training
- MHSYale School of Medicine (2019)
- National Clinician Scholars Program FellowYale University School of Medicine (2019)
- ResidentMontefiore Medical Center (2017)
- MDNew York University (2014)
- MPHNew York University (2014)
Activities
- Rates of Alcohol-Related Care Among Veterans with Unhealthy Alcohol Use by Long-Term Opioid Therapy ReceiptVirtual oral presentation 2021
- Timely access to methadone for opioid use disorder among Urban and Rural Opioid Treatment ProgramsVirtual oral presentation 2021
- Overdose risk and treatment access during the COVID-19 pandemic among individuals with opioid use disorderVirtual poster presentation 2021
- Small Area Accessibility Analysis of Medication for Opioid Use Disorder Providers in the Continental U.S.virtual poster presentation 2021
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Mack Lipkin, Sr. Associate Member Award Finalist for highest judged associate member abstract | Society General Internal Medicine | 2019 |
Solomon and Dora Shapiro Award for excellence based on scholarship, personality, and character | New York University School of Medicine | 2014 |
Professional Service
Organization | Role | Date |
---|---|---|
Substance Use and Misuse | Reviewer | 2021 - Present |
Journal of Appalachian Health | Reviewer | 2021 - Present |
Drug and Alcohol Dependence | Reviewer | 2021 - Present |
International Journal of Drug Policy | Reviewer | 2021 - Present |
Journal of General Internal Medicine | Reviewer | 2021 - Present |
Addiction Science and Clinical Practice | Reviewer | 2021 |
Health Services Insights | Reviewer | 2021 |
Drug and Alcohol Dependence | Reviewer | 2021 |
National Institute on Drug Abuse Clinical Trials Network | Methadone Task Force | 2020 - 2021 |
JAMA Psychiatry | Reviewer | 2020 |
Journal of Substance Abuse Treatment | Reviewer | 2020 |
Substance Abuse | Reviewer | 2020 |
Journal of Appalachian Health | Reviewer | 2020 |
Drug and Alcohol Dependence | Reviewer | 2020 |
North Central Ohio Harm Reduction | Community non-profit | 2020 - Present |
Journal of Addiction Medicine | Reviewer | 2019 |
Health Affairs | Reviewer | 2019 |
Journal of Substance Abuse Treatment | Reviewer | 2019 |
Addiction Science and Clinical Practice | Reviewer | 2018 |
JAMA Internal Medicine | Reviewer | 2018 |
City of New Haven | Law Enforcement Assisted Diversion Policy Group | 2017 - 2019 |